首页 > 最新文献

Jundishapur Journal of Microbiology最新文献

英文 中文
Comparison of Respiratory Microbiota in Patients with and Without Hospital-Acquired Infection 医院获得性感染患者与非医院获得性感染患者呼吸道微生物群比较
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-29 DOI: 10.5812/jjm-133257
Farzad Mohammadi Ebli, Z. Heshmatipour, K. Daneshjou, S. Siadat
Background: Nosocomial infections have increased among patients admitted to the intensive care unit (ICU). Objectives: This study investigated the microbiota pattern of the respiratory system in hospitalized patients with treatment-resistant respiratory infections compared to those without treatment-resistant respiratory infections. Methods: This case-control study utilized sputum samples from hospital-acquired infection (HAI) and non-HAI (NHAI) patients over 52 years old hospitalized in the ICU. Identification and determination of the drug sensitivity of the bacteria responsible for treatment-resistant respiratory infections were made by culture method in selective and differential media and VITEK 2 device. Finally, quantitative polymerase chain reaction (qPCR) was used to analyze the microbiota of the respiratory system. Results: Excessive prescription of antibiotics, long hospitalization, and history of surgery were important risk factors for nosocomial infections. The study of antibiotic resistance of pathogens causing hospital infections indicated their high resistance to most common antibiotics. Also, nosocomial infections led to a change in lung microbiota in HAI patients. The frequencies of Streptococcus pyogenes, S. pneumoniae, and Haemophilus influenzae were higher in patients with treatment-resistant respiratory infection (P < 0.05), but the frequency of Neisseria spp. was higher in patients without treatment-resistant respiratory infection (P < 0.05). Conclusions: The pathogens responsible for nosocomial infections had acquired resistance to a wide range of antibiotics, leading to changes in their respiratory microbiota.
背景:重症监护病房(ICU)住院患者的院内感染有所增加。目的:本研究探讨了治疗耐药呼吸道感染住院患者与非治疗耐药呼吸道感染住院患者呼吸系统的微生物群模式。方法:本病例对照研究使用医院获得性感染(HAI)和非HAI (NHAI)患者的痰样本,年龄大于52岁。采用选择性和差异培养基培养法和VITEK 2装置对耐药呼吸道感染病原菌进行药敏鉴定和测定。最后,采用定量聚合酶链反应(qPCR)对呼吸系统微生物群进行分析。结果:抗生素处方过量、住院时间长、手术史是院内感染的重要危险因素。医院感染病原菌的耐药性研究表明,病原菌对大多数常见抗生素具有较高的耐药性。此外,医院感染导致HAI患者肺部微生物群的变化。化脓性链球菌、肺炎链球菌和流感嗜血杆菌在治疗耐药呼吸道感染患者中出现频率较高(P < 0.05),而奈瑟菌在非治疗耐药呼吸道感染患者中出现频率较高(P < 0.05)。结论:引起医院感染的病原菌对多种抗生素产生耐药性,导致其呼吸道菌群发生变化。
{"title":"Comparison of Respiratory Microbiota in Patients with and Without Hospital-Acquired Infection","authors":"Farzad Mohammadi Ebli, Z. Heshmatipour, K. Daneshjou, S. Siadat","doi":"10.5812/jjm-133257","DOIUrl":"https://doi.org/10.5812/jjm-133257","url":null,"abstract":"Background: Nosocomial infections have increased among patients admitted to the intensive care unit (ICU). Objectives: This study investigated the microbiota pattern of the respiratory system in hospitalized patients with treatment-resistant respiratory infections compared to those without treatment-resistant respiratory infections. Methods: This case-control study utilized sputum samples from hospital-acquired infection (HAI) and non-HAI (NHAI) patients over 52 years old hospitalized in the ICU. Identification and determination of the drug sensitivity of the bacteria responsible for treatment-resistant respiratory infections were made by culture method in selective and differential media and VITEK 2 device. Finally, quantitative polymerase chain reaction (qPCR) was used to analyze the microbiota of the respiratory system. Results: Excessive prescription of antibiotics, long hospitalization, and history of surgery were important risk factors for nosocomial infections. The study of antibiotic resistance of pathogens causing hospital infections indicated their high resistance to most common antibiotics. Also, nosocomial infections led to a change in lung microbiota in HAI patients. The frequencies of Streptococcus pyogenes, S. pneumoniae, and Haemophilus influenzae were higher in patients with treatment-resistant respiratory infection (P < 0.05), but the frequency of Neisseria spp. was higher in patients without treatment-resistant respiratory infection (P < 0.05). Conclusions: The pathogens responsible for nosocomial infections had acquired resistance to a wide range of antibiotics, leading to changes in their respiratory microbiota.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45297229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients 丙型肝炎病毒在血液透析患者中的流行及其隐性感染
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-28 DOI: 10.5812/jjm-136504
M. Nakhaie, E. Taheri, J. Charostad, Nasir Arefinia, D. Kalantar-Neyestanaki, Mohammad Rezaei Zadeh Rukerd, F. Ahmadpour, Mohamad Hossein Pourebrahimi, Sara Ahmadinejad Farsangi, Sara Shafieipour
Background: Hepatitis C virus (HCV) is one of the most common infections in hemodialysis patients, which has been associated with increased incidence of morbidity and mortality, particularly in low- and middle-income countries. Objectives: The current study aimed to evaluate the HCV antibody, occult HCV infection (OCI), and related risk factors among hemodialysis patients. Methods: In this cross-sectional study, 100 hemodialysis patients referred to a dialysis center in Kerman between December 2021 and March 2022 were assessed for HCV, OCI, and their related risk factors. The information related to risk factors was collected by questionnaire, while HCV and OCI were detected through serology and real-time polymerase chain reaction (PCR) methods, respectively. Results: Among the patients participating in the study, 61 were men, and 39 were women. The average age was 58.1 ± 14.9 years in men and 63.6 ± 11.4 years in women. Diabetes and hypertension history, old age, low education, self-employment, and urban living were more common in chronic kidney disease patients. The enzyme-linked immunosorbent assay (ELISA) revealed 3% positive seroprevalence HCV infection, but only 1% was positive for OCI. Although no statistically significant relationship was found between the presence of HCV (antibody and OCI) and other parameters, all positive HCV cases were identified in patients with low education and freelance employment. Conclusions: Hemodialysis patients had a low prevalence of HCV antibody and OCI. Improving various factors and conditions such as lifestyle, occupation, educational level, and dialysis ward and machine disinfection could be beneficial in managing and controlling hemodialysis complications such as HCV and OCI.
背景:丙型肝炎病毒(HCV)是血液透析患者最常见的感染之一,它与发病率和死亡率的增加有关,特别是在中低收入国家。目的:本研究旨在评估血液透析患者的丙型肝炎病毒抗体、隐匿性丙型肝炎病毒感染(OCI)及其相关危险因素。方法:在这项横断面研究中,对2021年12月至2022年3月期间转诊至克尔曼透析中心的100名血液透析患者进行了HCV、OCI及其相关风险因素的评估。通过问卷调查收集与危险因素相关的信息,同时分别通过血清学和实时聚合酶链式反应(PCR)方法检测HCV和OCI。结果:在参与研究的患者中,61人为男性,39人为女性。男性平均年龄58.1±14.9岁,女性平均年龄63.6±11.4岁。糖尿病和高血压病史、老年、低学历、自营职业和城市生活在慢性肾脏病患者中更常见。酶联免疫吸附试验(ELISA)显示血清HCV感染阳性率为3%,但OCI阳性率仅为1%。尽管HCV(抗体和OCI)的存在与其他参数之间没有统计学上的显著关系,但所有阳性HCV病例都是在低教育和自由职业的患者中发现的。结论:血液透析患者HCV抗体和OCI的患病率较低。改善各种因素和条件,如生活方式、职业、教育水平、透析病房和机器消毒,可能有助于管理和控制血液透析并发症,如HCV和OCI。
{"title":"Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients","authors":"M. Nakhaie, E. Taheri, J. Charostad, Nasir Arefinia, D. Kalantar-Neyestanaki, Mohammad Rezaei Zadeh Rukerd, F. Ahmadpour, Mohamad Hossein Pourebrahimi, Sara Ahmadinejad Farsangi, Sara Shafieipour","doi":"10.5812/jjm-136504","DOIUrl":"https://doi.org/10.5812/jjm-136504","url":null,"abstract":"Background: Hepatitis C virus (HCV) is one of the most common infections in hemodialysis patients, which has been associated with increased incidence of morbidity and mortality, particularly in low- and middle-income countries. Objectives: The current study aimed to evaluate the HCV antibody, occult HCV infection (OCI), and related risk factors among hemodialysis patients. Methods: In this cross-sectional study, 100 hemodialysis patients referred to a dialysis center in Kerman between December 2021 and March 2022 were assessed for HCV, OCI, and their related risk factors. The information related to risk factors was collected by questionnaire, while HCV and OCI were detected through serology and real-time polymerase chain reaction (PCR) methods, respectively. Results: Among the patients participating in the study, 61 were men, and 39 were women. The average age was 58.1 ± 14.9 years in men and 63.6 ± 11.4 years in women. Diabetes and hypertension history, old age, low education, self-employment, and urban living were more common in chronic kidney disease patients. The enzyme-linked immunosorbent assay (ELISA) revealed 3% positive seroprevalence HCV infection, but only 1% was positive for OCI. Although no statistically significant relationship was found between the presence of HCV (antibody and OCI) and other parameters, all positive HCV cases were identified in patients with low education and freelance employment. Conclusions: Hemodialysis patients had a low prevalence of HCV antibody and OCI. Improving various factors and conditions such as lifestyle, occupation, educational level, and dialysis ward and machine disinfection could be beneficial in managing and controlling hemodialysis complications such as HCV and OCI.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47790979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbiological Profile and Drug Resistance in Bone and Joint Infections: A Survey in Orthopedic Wards of a Great Referral Hospital in Tehran, Iran 骨和关节感染的微生物学特征和耐药性:伊朗德黑兰一家大型转诊医院骨科病房的调查
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-24 DOI: 10.5812/jjm-137125
Samaneh Salarvand, A. Abdollahi, Masoumeh Doraghi, Seyed Amir Miratashi Yazdi, Z. Panahi, S. Mortazavi, E. Nazar
Background: Patients undergoing orthopedic surgery are at risk of nosocomial infections, and antibiotic resistance is known to increase the risk of such infections. Objectives: We aimed to determine the rate of antibiotic resistance in patients admitted to orthopedic wards in one of the largest referral hospitals in Iran. We also ascertained responsible antibiotic-resistant microorganisms in patients with bone and joint infections. Methods: The present cross-sectional investigation was concluded over a period of five years, from March 2018 to March 2022, at a great referral hospital in Tehran. Laboratory data, including the organisms isolated and their antibiotic resistance patterns, were collected by reviewing the hospital information system. Results: In total, 2650 specimens obtained from patients with suspected bacterial infections were transferred to the hospital’s laboratory, 880 (33.2%) of which were positive for bacterial infections. The maximum antibiotic resistance rate against an antibiotic was observed to be 58% for Staphylococcus aureus (erythromycin), 75% for Klebsiella pneumonia (ampicillin/sulbactam), 64.5% for Escherichia coli (imipenem), 76.2% for coagulase-negative Staphylococcus (vancomycin), 100% for Acinetobacter baumannii (imipenem), 52% for S. epidermidis (erythromycin), 85.9% for Enterobacter species (gentamycin), and 65.6% for Pseudomonas aeruginosa (ampicillin/sulbactam). The overall rate of multi-drug resistance was obtained as 27.6%. Conclusions: A high rate of resistance of various bacterial strains to common antibiotics, especially erythromycin, ampicillin, imipenem, vancomycin, and gentamycin, was denoted in orthopedic wards. Also, a high rate of multi-antibiotic resistance was encountered in these wards, where more than a quarter of the bacterial strains showed such resistance.
背景:接受骨科手术的患者存在院内感染的风险,已知抗生素耐药性会增加此类感染的风险。目的:我们的目的是确定在伊朗最大的转诊医院之一骨科病房住院的患者的抗生素耐药率。我们还确定了骨和关节感染患者的抗生素耐药微生物。方法:本横断面调查于2018年3月至2022年3月期间在德黑兰一家大型转诊医院完成。通过审查医院信息系统收集实验室数据,包括分离的微生物及其抗生素耐药性模式。结果:共收集疑似细菌感染患者标本2650份,其中细菌感染阳性880份(33.2%)。其中,金黄色葡萄球菌(红霉素)最高耐药率为58%,肺炎克雷伯菌(氨苄青霉素/舒巴坦)最高耐药率为75%,大肠杆菌(亚胺培南)最高耐药率为64.5%,凝固酶阴性葡萄球菌(万古霉素)最高耐药率为76.2%,鲍曼不动杆菌(亚胺培南)最高耐药率为100%,表皮葡萄球菌(红霉素)最高耐药率为52%,肠杆菌(庆大霉素)最高耐药率为85.9%,铜绿假单胞菌(氨苄青霉素/舒巴坦)最高耐药率为65.6%。总耐多药率为27.6%。结论:骨科病房各菌株对常用抗生素的耐药率较高,尤其是红霉素、氨苄西林、亚胺培南、万古霉素、庆大霉素。此外,在这些病房中,多种抗生素耐药率很高,其中超过四分之一的细菌菌株表现出这种耐药。
{"title":"Microbiological Profile and Drug Resistance in Bone and Joint Infections: A Survey in Orthopedic Wards of a Great Referral Hospital in Tehran, Iran","authors":"Samaneh Salarvand, A. Abdollahi, Masoumeh Doraghi, Seyed Amir Miratashi Yazdi, Z. Panahi, S. Mortazavi, E. Nazar","doi":"10.5812/jjm-137125","DOIUrl":"https://doi.org/10.5812/jjm-137125","url":null,"abstract":"Background: Patients undergoing orthopedic surgery are at risk of nosocomial infections, and antibiotic resistance is known to increase the risk of such infections. Objectives: We aimed to determine the rate of antibiotic resistance in patients admitted to orthopedic wards in one of the largest referral hospitals in Iran. We also ascertained responsible antibiotic-resistant microorganisms in patients with bone and joint infections. Methods: The present cross-sectional investigation was concluded over a period of five years, from March 2018 to March 2022, at a great referral hospital in Tehran. Laboratory data, including the organisms isolated and their antibiotic resistance patterns, were collected by reviewing the hospital information system. Results: In total, 2650 specimens obtained from patients with suspected bacterial infections were transferred to the hospital’s laboratory, 880 (33.2%) of which were positive for bacterial infections. The maximum antibiotic resistance rate against an antibiotic was observed to be 58% for Staphylococcus aureus (erythromycin), 75% for Klebsiella pneumonia (ampicillin/sulbactam), 64.5% for Escherichia coli (imipenem), 76.2% for coagulase-negative Staphylococcus (vancomycin), 100% for Acinetobacter baumannii (imipenem), 52% for S. epidermidis (erythromycin), 85.9% for Enterobacter species (gentamycin), and 65.6% for Pseudomonas aeruginosa (ampicillin/sulbactam). The overall rate of multi-drug resistance was obtained as 27.6%. Conclusions: A high rate of resistance of various bacterial strains to common antibiotics, especially erythromycin, ampicillin, imipenem, vancomycin, and gentamycin, was denoted in orthopedic wards. Also, a high rate of multi-antibiotic resistance was encountered in these wards, where more than a quarter of the bacterial strains showed such resistance.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45885285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial Diversity and Abundance in Pulmonary Tissue of Patients with Early-Stage Lung Cancer 早期肺癌患者肺组织微生物多样性和丰度
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-16 DOI: 10.5812/jjm-137478
Zhao Shouhua, L. Meilan
Background: The composition of lung tissue microorganisms in patients with different tissue types of lung cancer has not yet been determined. Previous studies have shown changes in the composition of pulmonary microbial flora in patients with lung cancer. Objectives: This study aimed to investigate the differences and correlations in the microbial flora of pulmonary tissue among different histological types of lung cancer. Methods: Samples of tumor and normal lung tissue from 29 patients with early-stage lung cancer were collected. The samples were sequenced using Illumina HiSeq high throughput sequencing technology for 16S rDNA in the V4 region of the bacteria. Also, their microbiological characteristics were detected, and bioinformatics analysis was performed. Results: The results of microbial abundance analysis in the lung tissue of patients with lung cancer showed that the bacterial colony composition of the two tissues was similar, with Proteobacteria, Thickwalled Bacteria, Anomalococcus, Bacteroides, and Actinobacteria predominating. Analysis of microbial diversity found no difference in α diversity and β diversity between normal lung tissue and tumor tissue. When analyzing patients with adenocarcinoma, the abundance of Micrococcales and Blastomonas was significantly higher in tumor tissue than in normal lung tissue. Conclusions: The composition of microbial flora in different parts of lung tissue of early-stage lung cancer patients is consistent, but the dominant flora varies among different histological types of lung cancer.
背景:癌症不同组织类型患者的肺组织微生物组成尚未确定。先前的研究表明,癌症患者肺部微生物菌群的组成发生了变化。目的:探讨癌症不同组织学类型肺组织微生物菌群的差异及其相关性。方法:收集29例早期癌症患者的肿瘤和正常肺组织标本。使用Illumina HiSeq高通量测序技术对细菌V4区域的16S rDNA进行测序。此外,还检测了它们的微生物特征,并进行了生物信息学分析。结果:癌症患者肺组织微生物丰度分析结果显示,两种组织的菌落组成相似,以变形菌、厚壁菌、异常球菌、拟杆菌和放线菌为主。微生物多样性分析发现,正常肺组织和肿瘤组织的α多样性和β多样性没有差异。在分析腺癌患者时,肿瘤组织中微球菌和芽胞菌的丰度显著高于正常肺组织。结论:早期癌症患者肺组织不同部位的微生物菌群组成一致,但癌症不同组织类型的优势菌群不同。
{"title":"Microbial Diversity and Abundance in Pulmonary Tissue of Patients with Early-Stage Lung Cancer","authors":"Zhao Shouhua, L. Meilan","doi":"10.5812/jjm-137478","DOIUrl":"https://doi.org/10.5812/jjm-137478","url":null,"abstract":"Background: The composition of lung tissue microorganisms in patients with different tissue types of lung cancer has not yet been determined. Previous studies have shown changes in the composition of pulmonary microbial flora in patients with lung cancer. Objectives: This study aimed to investigate the differences and correlations in the microbial flora of pulmonary tissue among different histological types of lung cancer. Methods: Samples of tumor and normal lung tissue from 29 patients with early-stage lung cancer were collected. The samples were sequenced using Illumina HiSeq high throughput sequencing technology for 16S rDNA in the V4 region of the bacteria. Also, their microbiological characteristics were detected, and bioinformatics analysis was performed. Results: The results of microbial abundance analysis in the lung tissue of patients with lung cancer showed that the bacterial colony composition of the two tissues was similar, with Proteobacteria, Thickwalled Bacteria, Anomalococcus, Bacteroides, and Actinobacteria predominating. Analysis of microbial diversity found no difference in α diversity and β diversity between normal lung tissue and tumor tissue. When analyzing patients with adenocarcinoma, the abundance of Micrococcales and Blastomonas was significantly higher in tumor tissue than in normal lung tissue. Conclusions: The composition of microbial flora in different parts of lung tissue of early-stage lung cancer patients is consistent, but the dominant flora varies among different histological types of lung cancer.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41420017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clostridium difficile Infection Risk Factors and Outcomes Among Inpatients Infected with NAP1/BI/027 Strain Compared to Non-NAP1 Strain in a Major Chinese Hospital 中国某大医院感染NAP1/BI/027菌株与非NAP1菌株住院患者艰难梭菌感染的危险因素及转归
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-16 DOI: 10.5812/jjm-136904
Guangyue Yao, Wenjia Wang, Chunhong Shao, Jing Shao, Hui Fan, Yuanyuan Bai
Background: NAP1/027 Clostridium difficile infection (CDI) has rarely been reported in China. Objectives: The objective of this study was to strengthen the understanding of the risk factors and outcomes of NAP1/027 CDI. Methods: A single-center, retrospective, case-control (1: 3) study was performed to identify risk factors and outcomes specific to NAP1/027 CDI using a group of patients with NAP1/027 CDI (n = 20) and a group of age-matched control patients with non-NAP1/027 CDI (n = 60) within June 2018 and August 2021. The patient charts were thoroughly reviewed to assess the markers of severity, risk factors, and outcomes. Results: Out of the 272 stool specimens, 41 cases (15.07%) tested positive for the NAP1 strain of C. difficile using the polymerase chain reaction. Among these specimens, 20 cases fulfilled the inclusion criteria. No significant difference was observed between the NAP1/027 and non-NAP1/027 groups in disease severity, length of hospital stay, or mortality. Logistic regression analysis revealed that risk factors for acquiring NAP1/027 infection included hospitalization in the 90 days before CDI diagnosis and high C-reactive protein level within ± 3 days of C. difficile detection. Conclusions: In a large non-epidemic tertiary hospital in China, NAP1/027 strains were more prevalent in patients with previous hospitalization and high CRP level than non-NAP1/027 strains.
背景:NAP1/027艰难梭菌感染(Clostridium difficile infection, CDI)在中国报道较少。目的:本研究的目的是加强对NAP1/027 CDI的危险因素和预后的认识。方法:采用2018年6月至2021年8月期间的NAP1/027 CDI患者组(n = 20)和非NAP1/027 CDI对照组(n = 60),进行单中心、回顾性、病例对照(1∶3)研究,以确定NAP1/027 CDI的危险因素和结局。对患者的病历进行全面审查,以评估严重程度、危险因素和结果。结果:272例粪便标本中,艰难梭菌NAP1聚合酶链反应阳性41例(15.07%)。其中20例符合纳入标准。NAP1/027组与非NAP1/027组在疾病严重程度、住院时间或死亡率方面无显著差异。Logistic回归分析显示,发生NAP1/027感染的危险因素包括CDI诊断前90天住院和艰难梭菌检测后±3天内c反应蛋白水平升高。结论:在国内某大型非流行病三级医院中,既往住院且CRP水平高的患者中NAP1/027株比非NAP1/027株更流行。
{"title":"Clostridium difficile Infection Risk Factors and Outcomes Among Inpatients Infected with NAP1/BI/027 Strain Compared to Non-NAP1 Strain in a Major Chinese Hospital","authors":"Guangyue Yao, Wenjia Wang, Chunhong Shao, Jing Shao, Hui Fan, Yuanyuan Bai","doi":"10.5812/jjm-136904","DOIUrl":"https://doi.org/10.5812/jjm-136904","url":null,"abstract":"Background: NAP1/027 Clostridium difficile infection (CDI) has rarely been reported in China. Objectives: The objective of this study was to strengthen the understanding of the risk factors and outcomes of NAP1/027 CDI. Methods: A single-center, retrospective, case-control (1: 3) study was performed to identify risk factors and outcomes specific to NAP1/027 CDI using a group of patients with NAP1/027 CDI (n = 20) and a group of age-matched control patients with non-NAP1/027 CDI (n = 60) within June 2018 and August 2021. The patient charts were thoroughly reviewed to assess the markers of severity, risk factors, and outcomes. Results: Out of the 272 stool specimens, 41 cases (15.07%) tested positive for the NAP1 strain of C. difficile using the polymerase chain reaction. Among these specimens, 20 cases fulfilled the inclusion criteria. No significant difference was observed between the NAP1/027 and non-NAP1/027 groups in disease severity, length of hospital stay, or mortality. Logistic regression analysis revealed that risk factors for acquiring NAP1/027 infection included hospitalization in the 90 days before CDI diagnosis and high C-reactive protein level within ± 3 days of C. difficile detection. Conclusions: In a large non-epidemic tertiary hospital in China, NAP1/027 strains were more prevalent in patients with previous hospitalization and high CRP level than non-NAP1/027 strains.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42625789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination Therapy with Ceftazidime-Avibactam and Amikacin for Multidrug-Resistant Pseudomonas aeruginosa Infection with Fulminant Myocarditis in a Younger Patient: A Case Report and Literature Review 头孢他啶-阿维巴坦联合阿米卡星治疗多药耐药铜绿假单胞菌合并暴发性心肌炎1例报告及文献复习
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-12 DOI: 10.5812/jjm-136894
Xiuhong Zhang, Sihui Cai, C. Chang, Qiuhui Wang, Weizhen Qiao
Introduction: Fulminant myocarditis is a life-threatening disease among young patients. Pseudomonas aeruginosa is distributed in nature and is often spread as an opportunistic pathogen to cause hospital-acquired infections in patients with underlying diseases and low immunity. Case Presentation: This report presented a case of a 28-year-old woman with fulminant myocarditis followed by P. aeruginosa infection. After hospitalization, she received veno-arterial extracorporeal membrane oxygenation (ECMO) and continuous renal replacement treatment (CRRT). Initially, piperacillin sodium tazobactam combined with amikacin was used for anti-infection therapy, which had a poor clinical effect. Subsequently, it was recommended to use ceftazidime-avibactam and amikacin for treatment. Finally, the infection index of the patient returned to normal. Conclusions: It is necessary to select correct and effective drugs according to etiology, considering the influence of ECMO and CRRT on the patient’s antimicrobial pharmacokinetics/pharmacodynamics (PK/PD). This case could provide a reference for safe and rational drug use in clinical practice.
前言:暴发性心肌炎是年轻患者中一种危及生命的疾病。铜绿假单胞菌在自然界中分布广泛,经常作为一种机会性病原体在有潜在疾病和免疫力低下的患者中传播,导致医院获得性感染。病例介绍:本报告介绍了一例28岁女性暴发性心肌炎并发铜绿假单胞菌感染的病例。住院后,她接受了静脉-动脉体外膜肺氧合(ECMO)和连续肾替代治疗(CRRT)。最初,哌拉西林钠-他唑巴坦联合阿米卡星用于抗感染治疗,临床效果不佳。随后,建议使用头孢他啶-阿维巴坦和阿米卡星进行治疗。最终,患者的感染指数恢复正常。结论:考虑ECMO和CRRT对患者抗菌药代动力学/药效学(PK/PD)的影响,有必要根据病因选择正确有效的药物。该病例可为临床安全合理用药提供参考。
{"title":"Combination Therapy with Ceftazidime-Avibactam and Amikacin for Multidrug-Resistant Pseudomonas aeruginosa Infection with Fulminant Myocarditis in a Younger Patient: A Case Report and Literature Review","authors":"Xiuhong Zhang, Sihui Cai, C. Chang, Qiuhui Wang, Weizhen Qiao","doi":"10.5812/jjm-136894","DOIUrl":"https://doi.org/10.5812/jjm-136894","url":null,"abstract":"Introduction: Fulminant myocarditis is a life-threatening disease among young patients. Pseudomonas aeruginosa is distributed in nature and is often spread as an opportunistic pathogen to cause hospital-acquired infections in patients with underlying diseases and low immunity. Case Presentation: This report presented a case of a 28-year-old woman with fulminant myocarditis followed by P. aeruginosa infection. After hospitalization, she received veno-arterial extracorporeal membrane oxygenation (ECMO) and continuous renal replacement treatment (CRRT). Initially, piperacillin sodium tazobactam combined with amikacin was used for anti-infection therapy, which had a poor clinical effect. Subsequently, it was recommended to use ceftazidime-avibactam and amikacin for treatment. Finally, the infection index of the patient returned to normal. Conclusions: It is necessary to select correct and effective drugs according to etiology, considering the influence of ECMO and CRRT on the patient’s antimicrobial pharmacokinetics/pharmacodynamics (PK/PD). This case could provide a reference for safe and rational drug use in clinical practice.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45967007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency, Bacteriological Profile, and Outcome of Neonatal Sepsis with Carbapenem-Resistant Gram-Negative Bacteria at the Tertiary Neonatal Intensive Care Unit, Ahvaz, Iran 伊朗阿瓦兹第三新生儿重症监护室感染碳青霉烯耐药革兰氏阴性菌的新生儿败血症的频率、细菌学特征和结果
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-12 DOI: 10.5812/jjm-134278
Seyyed Mohammad Hassan Aletayeb, M. Dehdashtian, A. Malakian, M. Aramesh, L. Kouti, Fateme Aletayeb
Background: One of the leading causes of neonatal mortality in low- and middle-income countries (LMICs) is neonatal sepsis caused by carbapenem-resistant gram-negative bacteria. Objectives: This study aimed to determine the frequency, bacterial profile, and outcome of carbapenem-resistant Gram-negative neonatal sepsis in southwest Iran. Methods: This 15-month retrospective cross-sectional descriptive study was conducted at a level 3 referral training hospital. The study included all neonates hospitalized from birth who had positive blood cultures for Gram-negative bacteria. Patients were divided into carbapenem-resistant and carbapenem-sensitive groups. Results: During the study, Gram-negative bacteria were isolated from the blood cultures of 113 neonates. Positive Gram-negative bacteria blood cultures and carbapenem-resistant cases were 2.38% and 1.52%, respectively. In these cases, 66 (58.4%) of the infants were males, 100 (88.4%) were preterm, and 74 (65.4%) required mechanical ventilation within the first three days of life. The study found 45 (39.8%) infants with early-onset sepsis. Acinetobacter was the most common isolated organism, while Enterobacter had the lowest isolation rate. Carbapenem resistance was discovered in 72 (63.7%) positive blood cultures. Acinetobacter had the highest prevalence of carbapenem resistance, while Pseudomonas had the lowest. Mortality rates in infants infected with carbapenem resistance bacteria (CRB) were 89.3% compared to 10.7% in those infected with carbapenem-sensitive bacteria (CSB). Conclusions: The frequency of carbapenem-resistant Gram-negative sepsis in our ward was 1.52 percent of all admissions, and Acinetobacter bacteria was the most common cause of this type of neonatal sepsis. Infants infected with CRB had a higher mortality rate than those infected with CSB, 89.3% versus 10.7%.
背景:低收入和中等收入国家(LMICs)新生儿死亡的主要原因之一是由碳青霉烯耐药革兰氏阴性菌引起的新生儿败血症。目的:本研究旨在确定伊朗西南部新生儿碳青霉烯耐药革兰氏阴性败血症的频率、细菌谱和结局。方法:在一家三级转诊培训医院进行为期15个月的回顾性横断面描述性研究。该研究包括所有从出生起就住院的革兰氏阴性菌血培养阳性的新生儿。患者分为碳青霉烯耐药组和碳青霉烯敏感组。结果:在研究过程中,从113例新生儿血液培养中分离到革兰氏阴性菌。革兰氏阴性菌血培养阳性和碳青霉烯耐药病例分别为2.38%和1.52%。在这些病例中,66例(58.4%)为男婴,100例(88.4%)为早产儿,74例(65.4%)在出生后三天内需要机械通气。该研究发现45例(39.8%)婴儿患有早发性败血症。不动杆菌是最常见的分离菌,肠杆菌的分离率最低。72例(63.7%)血培养阳性发现碳青霉烯类耐药。碳青霉烯耐药率最高的是不动杆菌,最低的是假单胞菌。碳青霉烯耐药菌(CRB)感染的婴儿死亡率为89.3%,而碳青霉烯敏感菌(CSB)感染的婴儿死亡率为10.7%。结论:我们病房碳青霉烯耐药革兰氏阴性脓毒症的发生率为1.52%,不动杆菌是这类新生儿脓毒症的最常见原因。感染CRB的婴儿死亡率高于感染CSB的婴儿,分别为89.3%和10.7%。
{"title":"Frequency, Bacteriological Profile, and Outcome of Neonatal Sepsis with Carbapenem-Resistant Gram-Negative Bacteria at the Tertiary Neonatal Intensive Care Unit, Ahvaz, Iran","authors":"Seyyed Mohammad Hassan Aletayeb, M. Dehdashtian, A. Malakian, M. Aramesh, L. Kouti, Fateme Aletayeb","doi":"10.5812/jjm-134278","DOIUrl":"https://doi.org/10.5812/jjm-134278","url":null,"abstract":"Background: One of the leading causes of neonatal mortality in low- and middle-income countries (LMICs) is neonatal sepsis caused by carbapenem-resistant gram-negative bacteria. Objectives: This study aimed to determine the frequency, bacterial profile, and outcome of carbapenem-resistant Gram-negative neonatal sepsis in southwest Iran. Methods: This 15-month retrospective cross-sectional descriptive study was conducted at a level 3 referral training hospital. The study included all neonates hospitalized from birth who had positive blood cultures for Gram-negative bacteria. Patients were divided into carbapenem-resistant and carbapenem-sensitive groups. Results: During the study, Gram-negative bacteria were isolated from the blood cultures of 113 neonates. Positive Gram-negative bacteria blood cultures and carbapenem-resistant cases were 2.38% and 1.52%, respectively. In these cases, 66 (58.4%) of the infants were males, 100 (88.4%) were preterm, and 74 (65.4%) required mechanical ventilation within the first three days of life. The study found 45 (39.8%) infants with early-onset sepsis. Acinetobacter was the most common isolated organism, while Enterobacter had the lowest isolation rate. Carbapenem resistance was discovered in 72 (63.7%) positive blood cultures. Acinetobacter had the highest prevalence of carbapenem resistance, while Pseudomonas had the lowest. Mortality rates in infants infected with carbapenem resistance bacteria (CRB) were 89.3% compared to 10.7% in those infected with carbapenem-sensitive bacteria (CSB). Conclusions: The frequency of carbapenem-resistant Gram-negative sepsis in our ward was 1.52 percent of all admissions, and Acinetobacter bacteria was the most common cause of this type of neonatal sepsis. Infants infected with CRB had a higher mortality rate than those infected with CSB, 89.3% versus 10.7%.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46809742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increasing Antimicrobial Resistance of Gram-Positive Cocci in the Nostrils of Health Care Workers in the Post–COVID-19 Era Compared to Pre–COVID-19 Era in North Khorasan, Iran 伊朗北呼罗珊地区后covid -19时代与前covid -19时代相比,医护人员鼻孔中革兰氏阳性球菌耐药性增加
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-12 DOI: 10.5812/jjm-135551
R. Besharati, Hatef Ajoudanifar, H. Ghasemzadeh-moghaddam, A. Azimian
Background: In the COVID-19 era, co-infections can lead to an increase in morbidity and mortality. Normal flora bacteria can transfer to the pulmonary tract and create bacterial co-infections. The nasal cavity is one of the main areas housing normal flora in the human body. Objectives: In this study, we evaluated the prevalence and antibiotic resistance of gram-positive cocci in the pre– and post–COVID-19 eras among health care workers. Methods: We assessed 376 nasal swabs from the pre–COVID-19 era and 376 from the post–COVID-19 era. Conventional and molecular methods were used to identify bacterial types and evaluate antimicrobial resistance. Results: The most common gram-positive cocci in the pre–COVID-19 samples were Staphylococcus aureus, S. epidermidis, S. capitis, S. hominis, S. haemolyticus, Streptococcus pneumoniae, and Enterococcus faecalis. In the post–COVID-19 samples, the most common gram-positive cocci were S. aureus, S. epidermidis, S. warneri, S. hominis, and E. faecalis. We observed higher resistance rates in post–COVID-19 samples, as well as resistance to linezolid and vancomycin in S. aureus, S. epidermidis, and S. hominis. Additionally, our isolates showed a high resistance rate to antiseptics. Conclusions: It seems that after the beginning of the COVID-19 pandemic, due to the change in the protective procedures in hospitals, the prevalence and variety of bacteria have decreased, but instead, they have been replaced by more pathogenic bacteria with higher antibiotic resistance.
背景:在新冠肺炎时代,合并感染可能导致发病率和死亡率增加。正常菌群细菌可以转移到肺部并产生细菌共感染。鼻腔是人体内容纳正常菌群的主要区域之一。目的:在本研究中,我们评估了新冠肺炎前后医护人员中革兰氏阳性球菌的流行率和抗生素耐药性。方法:我们评估了376份新冠肺炎前时期和376份新冠肺炎后时期的鼻拭子。常规和分子方法用于鉴定细菌类型和评估抗微生物耐药性。结果:新冠肺炎前样本中最常见的革兰氏阳性球菌为金黄色葡萄球菌、表皮葡萄球菌、头状葡萄球菌、人型葡萄球菌、溶血性葡萄球菌、肺炎链球菌和粪肠球菌。在新冠肺炎后样本中,最常见的革兰氏阳性球菌为金黄色葡萄球菌、表皮葡萄球菌、华氏葡萄球菌、人型葡萄球菌和粪大肠杆菌。我们在新冠肺炎后样本中观察到较高的耐药性,以及金黄色葡萄球菌、表皮葡萄球菌和人型葡萄球菌对利奈唑胺和万古霉素的耐药性。此外,我们的分离株对防腐剂表现出很高的耐药性。结论:新冠肺炎大流行开始后,由于医院防护程序的改变,细菌的流行率和种类似乎有所下降,但取而代之的是更多具有更高抗生素耐药性的致病菌。
{"title":"Increasing Antimicrobial Resistance of Gram-Positive Cocci in the Nostrils of Health Care Workers in the Post–COVID-19 Era Compared to Pre–COVID-19 Era in North Khorasan, Iran","authors":"R. Besharati, Hatef Ajoudanifar, H. Ghasemzadeh-moghaddam, A. Azimian","doi":"10.5812/jjm-135551","DOIUrl":"https://doi.org/10.5812/jjm-135551","url":null,"abstract":"Background: In the COVID-19 era, co-infections can lead to an increase in morbidity and mortality. Normal flora bacteria can transfer to the pulmonary tract and create bacterial co-infections. The nasal cavity is one of the main areas housing normal flora in the human body. Objectives: In this study, we evaluated the prevalence and antibiotic resistance of gram-positive cocci in the pre– and post–COVID-19 eras among health care workers. Methods: We assessed 376 nasal swabs from the pre–COVID-19 era and 376 from the post–COVID-19 era. Conventional and molecular methods were used to identify bacterial types and evaluate antimicrobial resistance. Results: The most common gram-positive cocci in the pre–COVID-19 samples were Staphylococcus aureus, S. epidermidis, S. capitis, S. hominis, S. haemolyticus, Streptococcus pneumoniae, and Enterococcus faecalis. In the post–COVID-19 samples, the most common gram-positive cocci were S. aureus, S. epidermidis, S. warneri, S. hominis, and E. faecalis. We observed higher resistance rates in post–COVID-19 samples, as well as resistance to linezolid and vancomycin in S. aureus, S. epidermidis, and S. hominis. Additionally, our isolates showed a high resistance rate to antiseptics. Conclusions: It seems that after the beginning of the COVID-19 pandemic, due to the change in the protective procedures in hospitals, the prevalence and variety of bacteria have decreased, but instead, they have been replaced by more pathogenic bacteria with higher antibiotic resistance.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42209310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Drug Resistance, Virulence, and Phylogeny of Klebsiella pneumoniae in Patients with Different Infections 肺炎克雷伯菌不同感染者的耐药性、毒力及系统发育分析
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-07-12 DOI: 10.5812/jjm-133082
Jianhua Liu, Rui Li, Shukun Qian, J. Xi
Background: Klebsiella pneumoniae is an important pathogen among nosocomial infections, which can cause urinary and respiratory system infections, surgical site infections, and sepsis. Recently, carbapenem-resistant K. pneumoniae showed an upward trend with the wide use of clinical carbapenem antibiotics. However, there are few studies on the relationship between drug resistance, virulence, and phylogeny of K. pneumoniae in patients with different infections. Objectives: We investigated the drug resistance, virulence, and phylogeny of K. pneumoniae in patients with different infections. Methods: Seventy infected patients were selected as subjects. The extended-spectrum β-lactamases (ESBLs) color screening plane and blood plate medium were used for culture. Identification and drug resistance analysis was carried out by VITEK-2 compact automatic bacterial analyzer. Multilocus sequence typing (MLST) and capsule genotyping analysis were also performed. The Xpert CarbaR cartridge detected the carbapenem resistance genes. Comprehensive Antibiotic Research Database (CARD) and Virulence Factor Database (VFDB) predicted the drug-resistant genes and virulence factor genes, respectively. The phylogenetic tree was constructed, and the correlation was analyzed. Results: A total of 43 K. pneumoniae strains were cultured. We found that all K. pneumoniae strains exhibited different multiple drug resistance. MLST analysis indicated that ST11 was the main ST (60.61%). Analysis of the carbapenem-resistance genes showed that all isolates harbored the blaKPC-2 gene and some others blaOXA. The prediction result of capsular blood genotyping and virulence factor genes indicated that K47, K64, and K25 were the main types of capsular blood, and the top three detection rates of virulence genes were fimH (97.67%), mrkD (94.19%), and entB (84.88%). All isolates were clustered into one branch based on the virulence factor genes in the phylogenetic tree, and the strains of the same ST type or capsular blood type showed a closer relationship. Correlation analysis manifested that the drug resistance of K. pneumoniae in infected patients was positively correlated with virulence and phylogeny (r = 0.682, P = 0.000). Conclusions: There were complicated differences in the multidrug resistance to K. pneumoniae, resulting in high independent gene-positive rates of strains and a strong correlation with phylogeny, which can provide a reference for the selection of clinical antimicrobial drugs.
背景:肺炎克雷伯菌是医院感染中的一种重要病原体,可引起泌尿系统和呼吸系统感染、手术部位感染和败血症。近年来,随着临床碳青霉烯类抗生素的广泛使用,耐碳青霉烯的肺炎克雷伯菌呈上升趋势。然而,很少有研究表明肺炎克雷伯菌在不同感染患者中的耐药性、毒力和系统发育之间的关系。目的:研究肺炎克雷伯菌在不同感染患者中的耐药性、毒力和系统发育。方法:选择70例感染者作为研究对象。采用超广谱β-内酰胺酶(ESBLs)彩色筛选平面和血平板培养基进行培养。采用VITEK-2型小型全自动细菌分析仪进行鉴定和耐药性分析。还进行了多基因座序列分型(MLST)和胶囊分型分析。Xpert CarbaR试剂盒检测到碳青霉烯抗性基因。抗生素综合研究数据库(CARD)和毒力因子数据库(VFDB)分别预测了耐药基因和毒力因子基因。构建了系统发育树,并对其相关性进行了分析。结果:共培养出43株肺炎克雷伯菌。我们发现所有肺炎克雷伯菌菌株都表现出不同的多重耐药性。MLST分析表明,ST11是主要的ST(60.61%)。对碳青霉烯类抗生素抗性基因的分析表明,所有分离株都携带blaKPC-2基因和其他一些blaOXA基因。荚膜血基因分型和毒力因子基因预测结果表明,K47、K64和K25是荚膜血的主要类型,毒力基因检测率前三位分别为fimH(97.67%)、mrkD(94.19%)和entB(84.88%),同一ST型或荚膜血型菌株之间的关系更为密切。相关性分析表明,肺炎克雷伯菌感染患者的耐药性与毒力和系统发育呈正相关(r=0.682,P=0.000),可为临床抗菌药物的选择提供参考。
{"title":"Analysis of Drug Resistance, Virulence, and Phylogeny of Klebsiella pneumoniae in Patients with Different Infections","authors":"Jianhua Liu, Rui Li, Shukun Qian, J. Xi","doi":"10.5812/jjm-133082","DOIUrl":"https://doi.org/10.5812/jjm-133082","url":null,"abstract":"Background: Klebsiella pneumoniae is an important pathogen among nosocomial infections, which can cause urinary and respiratory system infections, surgical site infections, and sepsis. Recently, carbapenem-resistant K. pneumoniae showed an upward trend with the wide use of clinical carbapenem antibiotics. However, there are few studies on the relationship between drug resistance, virulence, and phylogeny of K. pneumoniae in patients with different infections. Objectives: We investigated the drug resistance, virulence, and phylogeny of K. pneumoniae in patients with different infections. Methods: Seventy infected patients were selected as subjects. The extended-spectrum β-lactamases (ESBLs) color screening plane and blood plate medium were used for culture. Identification and drug resistance analysis was carried out by VITEK-2 compact automatic bacterial analyzer. Multilocus sequence typing (MLST) and capsule genotyping analysis were also performed. The Xpert CarbaR cartridge detected the carbapenem resistance genes. Comprehensive Antibiotic Research Database (CARD) and Virulence Factor Database (VFDB) predicted the drug-resistant genes and virulence factor genes, respectively. The phylogenetic tree was constructed, and the correlation was analyzed. Results: A total of 43 K. pneumoniae strains were cultured. We found that all K. pneumoniae strains exhibited different multiple drug resistance. MLST analysis indicated that ST11 was the main ST (60.61%). Analysis of the carbapenem-resistance genes showed that all isolates harbored the blaKPC-2 gene and some others blaOXA. The prediction result of capsular blood genotyping and virulence factor genes indicated that K47, K64, and K25 were the main types of capsular blood, and the top three detection rates of virulence genes were fimH (97.67%), mrkD (94.19%), and entB (84.88%). All isolates were clustered into one branch based on the virulence factor genes in the phylogenetic tree, and the strains of the same ST type or capsular blood type showed a closer relationship. Correlation analysis manifested that the drug resistance of K. pneumoniae in infected patients was positively correlated with virulence and phylogeny (r = 0.682, P = 0.000). Conclusions: There were complicated differences in the multidrug resistance to K. pneumoniae, resulting in high independent gene-positive rates of strains and a strong correlation with phylogeny, which can provide a reference for the selection of clinical antimicrobial drugs.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43725061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Most Common Viral Causes of Fever and Neutropenia in Children Hospitalized in Abuzar Children’s Medical Center in Ahvaz, Iran 伊朗阿瓦兹阿布扎尔儿童医疗中心住院儿童发热和中性粒细胞减少症最常见病毒原因的评估
IF 0.6 4区 医学 Q4 Medicine Pub Date : 2023-06-16 DOI: 10.5812/jjm-135198
A. Shamsizadeh, N. Neisi, Seyede Shabnam Seyedsalehi, M. Fathi, Mohsen Alisamir, Seyed Mohammadreza Mirkarimi
Background: Viral infections are the most common cause of fever and neutropenia in children without underlying disease, and data are still limited in this regard. Objective: This study aimed to identify the most common viral causes of fever and neutropenia in pediatrics. Methods: This descriptive-analytical study was conducted on pediatric patients younger than 18 years old referred to the pediatric emergency ward with fever as the chief complaint and no underlying diseases; patients with neutropenia and no evidence of bacterial infections in terms of different cultures were included in the study. After obtaining parental consent, nasopharyngeal swab specimens were taken from patients during the coronavirus disease 2019 (COVID-19) pandemic, and blood samples were analyzed to detect viruses in each patient. Results: Fifty patients (54.3%) had mild neutropenia (absolute neutrophil count (ANC): 1000 - 1500/μL), 40 patients (43.5%) had moderate neutropenia (ANC: 1000 - 500/μL), and 2 cases (2.2%) had severe neutropenia (ANC < 500/μL). Among all the cases, 19 cases were positive in terms of virus examination, including adenovirus (6.5%), enterovirus (5.4%), cytomegalovirus (CMV) (3.3%), Epstein-Barr virus (EBV) (3.3%), and Herpes virus 6 (2.2%). A significant correlation was found between enterovirus and neutropenia (P = 0.005). Conclusions: The most common viruses found in neutropenic children hospitalized due to fever without any underlying disease were adenovirus and enterovirus, respectively. Considering the good general condition and relatively quick recovery, consideration of viral causes is recommended in this category of patients, and it is better to avoid prescribing broad-spectrum antibiotics, and careful follow-up should be carried out.
背景:病毒感染是没有潜在疾病的儿童发烧和中性粒细胞减少症的最常见原因,这方面的数据仍然有限。目的:本研究旨在确定儿科发热和中性粒细胞减少症最常见的病毒原因。方法:对转诊至儿科急诊病房的18岁以下以发热为主要主诉且无潜在疾病的儿童患者进行描述性分析研究;研究中包括了中性粒细胞减少症患者,并且在不同培养物中没有细菌感染的证据。在获得父母同意后,在2019冠状病毒病(新冠肺炎)大流行期间,从患者身上采集鼻咽拭子样本,并分析血液样本以检测每个患者的病毒。结果:50例(54.3%)患者出现轻度中性粒细胞减少症(中性粒细胞绝对计数(ANC):1000-1500/μL),40例(43.5%)患者出现中度中性粒细胞降低症(ANC:1000-500/μL,2例(2.2%)患者出现重度中性粒细胞减少症(ANC<500/μL)。在所有病例中,19例病毒检测呈阳性,包括腺病毒(6.5%)、肠道病毒(5.4%)、巨细胞病毒(CMV)(3.3%)、EB病毒(3.3%),和疱疹病毒6型(2.2%)。肠道病毒和中性粒细胞减少症之间存在显著相关性(P=0.005)。考虑到一般情况良好,恢复相对较快,建议这类患者考虑病毒原因,最好避免开广谱抗生素,并应仔细随访。
{"title":"Evaluation of the Most Common Viral Causes of Fever and Neutropenia in Children Hospitalized in Abuzar Children’s Medical Center in Ahvaz, Iran","authors":"A. Shamsizadeh, N. Neisi, Seyede Shabnam Seyedsalehi, M. Fathi, Mohsen Alisamir, Seyed Mohammadreza Mirkarimi","doi":"10.5812/jjm-135198","DOIUrl":"https://doi.org/10.5812/jjm-135198","url":null,"abstract":"Background: Viral infections are the most common cause of fever and neutropenia in children without underlying disease, and data are still limited in this regard. Objective: This study aimed to identify the most common viral causes of fever and neutropenia in pediatrics. Methods: This descriptive-analytical study was conducted on pediatric patients younger than 18 years old referred to the pediatric emergency ward with fever as the chief complaint and no underlying diseases; patients with neutropenia and no evidence of bacterial infections in terms of different cultures were included in the study. After obtaining parental consent, nasopharyngeal swab specimens were taken from patients during the coronavirus disease 2019 (COVID-19) pandemic, and blood samples were analyzed to detect viruses in each patient. Results: Fifty patients (54.3%) had mild neutropenia (absolute neutrophil count (ANC): 1000 - 1500/μL), 40 patients (43.5%) had moderate neutropenia (ANC: 1000 - 500/μL), and 2 cases (2.2%) had severe neutropenia (ANC < 500/μL). Among all the cases, 19 cases were positive in terms of virus examination, including adenovirus (6.5%), enterovirus (5.4%), cytomegalovirus (CMV) (3.3%), Epstein-Barr virus (EBV) (3.3%), and Herpes virus 6 (2.2%). A significant correlation was found between enterovirus and neutropenia (P = 0.005). Conclusions: The most common viruses found in neutropenic children hospitalized due to fever without any underlying disease were adenovirus and enterovirus, respectively. Considering the good general condition and relatively quick recovery, consideration of viral causes is recommended in this category of patients, and it is better to avoid prescribing broad-spectrum antibiotics, and careful follow-up should be carried out.","PeriodicalId":17803,"journal":{"name":"Jundishapur Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43577173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jundishapur Journal of Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1